Statistics

Fresenius Medical Care is the global leader in renal care and operates in more than 100 countries of the world. The company offers its dialysis services and dialysis products to thousands of patients in hundreds of clinics worldwide. The impressive growth rates of the recent past were accompanied by an increase of the number of patients receiving dialysis treatment by Fresenius Medical Care in an expanded network of company-owned dialysis facilities. The tables and graphics below provide an overview of these development since 1997.

Fresenius Medical Care is organised in four major business regions. The International part comprises of Europe/Middle East/Africa, Latin America and Asia-Pacific.


Number of Patients since 1997

Year
Total
North America
International
1997
68,000
53,500
14,500
1998
74,200
58,600
15,600
1999
80,000
62,000
18,000
2000
91,900
67,900
24,000
2001
105,830
76,900
29,230
2002
112,200
79,600
32,600
2003
119,250
82,400
36,850
2004
124,400
85,500
38,900
2005
131,450
89,300
42,150
2006
163,517
117,855
45,662
2007
173,863
121,431
52,432
H1 2008
179,340
123,784
55,556
Since Q2 2006 including acquisition of RCG.




Number of Treatments since 1997

Year
Total
North America
International
1997
9,100,000
7,200,000
1,900,000
1998
10,500,000
8,200,000
2,300,000
1999
11,400,000
8,900,000
2,500,000
2000
12,900,000
9,600,000
3,300,000
2001
15,200,000
11,100,000
4,100,000
2002
16,385,000
11,640,000
4,745,000
2003
17,830,000
12,370,000
5,460,000
2004
18,800,000
12,910,000
5,890,000
2005
19,730,000
13,470,000
6,260,000
2006
23,739,733
16,877,911
6,861,822
2007
26,442,421
18,451,381
7,991,040
H1 2008
13,609,491
9,392,170
4,217,321
Since Q2 2006 including acquisition of RCG.




Number of Clinics since 1997

Year
Total
North America
International
1997
908
715
193
1998
1,000
782
218
1999
1,090
849
241
2000
1,270
920
350
2001
1,400
1,030
370
2002
1,480
1,080
400
2003
1,560
1,110
450
2004
1,610
1,130
480
2005
1,680
1,155
525
2006
2,108
1,560
548
2007
2,238
1,602
636
H1 2008
2,318
1,647
671
Since Q2 2006 including acquisition of RCG.



top